Pfizer’s clinical trial data for their experimental COVID-19 injection showed one in five children aged 2-5 developed serious fevers.
In his latest update from “Unreported Truths,” Alex Berenson pointed out the frightening data released by Pfizer to their investors.
The company is struggling to figure out the dosages for the young age group.
Here’s a hint for Pfizer: the correct dosage is these kids don’t need your toxic injections.
Stop experimenting on innocent children!
Severe fevers in kids: Troubling data about Pfizer's Covid vaccine and children… from Pfizer's own clinical trial https://t.co/lJQ0EDY9Y8
— Vicki McKenna (@VickiMcKenna) January 4, 2022
Pfizer’s vaccine shows dose-related side effects in children; still, the company is letting five-year-olds receive an mRNA dosage that caused serious fevers in slightly younger kids.https://t.co/T0Yy6GL4At
— Andrew Bostom, MD, MS (@andrewbostom) January 4, 2022
20% of kids had severe fever from Pfizer jab… from Pfizer's own clinical trial. Don't experiment on your kids. https://t.co/YWpy1SiQ0i
— Better Maine (@MaineLogic) January 4, 2022
Berenson stated in his Substack “Unreported Truths:”
Fevers in kids 2-5 who received 10 micrograms of mRNA were both more common and more severe than those in other children tested with the vaccine, the company found. The side effect occurred after both the first and second vaccine dose.
While Pfizer hasn’t moved forward with the 10-microgram two-dose regimen for children aged 2-5, the company allowed 5-12-year-olds to receive the same dosage.
In their ongoing trial for children under 5, Pfizer is testing a much smaller 3-microgram dose.
An alarming aspect of Pfizer’s COVID-19 jab is the dosage isn’t adjusted by weight.
For example, a five-year-old that’s the size of a typical three or four-year-old would receive the 10-microgram dose that presents a risk of severe fever.
Slide #23 of a slideshow presentation prepared for investors on December 17th shows children aged 2-5 were the most affected group in the clinical trial.
Additionally, “Pfizer has not published any safety or efficacy data for its vaccine in children under 5 in a peer-reviewed journal,” reports the former New York Times journalist.
In their update, Pfizer said it would amend the study to evaluate a 3-microgram dose for children aged 6-months to 5-years-old.
Pfizer’s press release also admitted the company’s going on to test a third jab of the 3-microgram dose in children aged 2-5 after failing non-inferiority trials, further illustrating dosing challenges.
“Pfizer has not published any safety or efficacy data for its vaccine in children under 5 in a peer-reviewed journal,” Berenson notes, which means parents unfortunately have to trust data from the very company producing the vaccine.
Children have extremely little risk from severe COVID-19 complications.
Parents who allow their children to participate in this medical experiment are risking long-term damage to organs from these mRNA gene therapy injections.
Dr. Robert Malone, mRNA vaccine technology inventor, issued an urgent warning for parents not to inject their children with the experimental shots.